氯氮平
參考文獻

1 2 3  . Drugs.com.   [28 February 2017]. （原始内容存档于1 March 2017）.
↑  Hopfinger A, Esposito EX, Llinas A, Glen RC, Goodman JM. . Journal of Chemical Information and Modeling. 2009, 49: 1–5. PMID 19117422. doi:10.1021/ci800436c.
1 2 3 4 5 6 7 8 9 10  . The American Society of Health-System Pharmacists.   [Dec 1, 2015]. （原始内容存档于2015-12-08）.
1 2 3  Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; Engel, Rolf R; Geddes, John R; Kissling, Werner; Stapf, Marko Paul; Lässig, Bettina; Salanti, Georgia; Davis, John M. . The Lancet. 2013, 382 (9896): 951–62. PMID 23810019. doi:10.1016/S0140-6736(13)60733-3.
↑  Essali, A; Al-Haj Haasan, N; Li, C; Rathbone, J. . The Cochrane Database of Systematic Reviews. 21 January 2009, (1): CD000059. PMID 19160174. doi:10.1002/14651858.CD000059.pub2.
↑  Siskind, D; McCartney, L; Goldschlager, R; Kisely, S. . The British journal of psychiatry : the journal of mental science. 7 July 2016, 209: 385–392. PMID 27388573. doi:10.1192/bjp.bp.115.177261.
1 2  Hartling, L; Abou-Setta, AM; Dursun, S; Mousavi, SS; Pasichnyk, D; Newton, AS. . Annals of Internal Medicine. 2 October 2012, 157 (7): 498–511. PMID 22893011. doi:10.7326/0003-4819-157-7-201210020-00525.
1 2  Crilly, John. . History of Psychiatry. 2007-03-01, 18 (1): 39–60. ISSN 0957-154X. PMID 17580753. doi:10.1177/0957154X07070335. （原始内容存档于2016-07-10） （英语）.
↑  Corey, edited by Jie Jack Li, E.J. . Hoboken, N.J.: John Wiley & Sons. 2013: 248. ISBN 9781118354469. （原始内容存档于2017-09-08）.
↑   (PDF). World Health Organization. April 2015  [8 December 2016]. （原始内容存档 (PDF)于13 December 2016）.
↑  . International Drug Price Indicator Guide.   [2 December 2015]. （原始内容存档于2018年1月22日）.
1 2  Essali, A; Al-Haj Haasan, N; Li, C; Rathbone, J. . The Cochrane Database of Systematic Reviews. 21 January 2009, (1): CD000059. PMID 19160174. doi:10.1002/14651858.CD000059.pub2.
↑  Meltzer HY. . Current Medical Research and Opinion. 1997, 14 (1): 1–20. PMID 9524789. doi:10.1185/03007999709113338.
↑  Lee M, Dickson RA, Campbell M, Oliphant J, Gretton H, Dalby JT. . Canadian Journal of Psychiatry. 1998, 43: 855–856.
↑  . （原始内容存档于2013-12-11）.
↑  . （原始内容存档于2013-11-10）.
↑  . www.clinicalpharmacology-ip.com.   [2019-03-10]. （原始内容存档于2021-08-28）.
↑  . （原始内容存档于2013-11-10）.
↑  Baggaley M. . Human Psychopharmacology. Apr 2008, 23 (3): 201–209. PMID 18338766. doi:10.1002/hup.924.
↑  Nielsen J, Correll CU, Manu P, Kane JM. . The Journal of Clinical Psychiatry. Jun 2013, 74 (6): 603–13. PMID 23842012. doi:10.4088/JCP.12r08064.
↑  Baldessarini, Ross J.; Frank I. Tarazi. . Laurence Brunton; John Lazo; Keith Parker  (编).  11th. New York: McGraw-Hill. 2006. ISBN 978-0-07-142280-2. OCLC 150149056.
↑  Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. . The New England Journal of Medicine. Jul 1993, 329 (3): 162–7. PMID 8515788. doi:10.1056/NEJM199307153290303.  Free full text with registration 的存檔，存档日期2007-10-20.
↑  Midbari Y, Ebert T, Kosov I, Kotler M, Weizman A, Ram A. . Journal of Child and Adolescent Psychopharmacology. Oct 2013, 23 (8): 516–21. PMID 24111981. doi:10.1089/cap.2013.0050.
↑  Haas SJ, Hill R, Krum H, Liew D, Tonkin A, Demos L, Stephan K, McNeil J. . Drug Safety. 2007, 30 (1): 47–57. PMID 17194170. doi:10.2165/00002018-200730010-00005.
↑  Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. . The Australian and New Zealand Journal of Psychiatry. Jun 2011, 45 (6): 458–465. PMID 21524186. doi:10.3109/00048674.2011.572852.
↑  Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, Wolfe R, McNeil JJ. . Schizophrenia Research. Nov 2012, 141 (2–3): 173–8. PMID 23010488. doi:10.1016/j.schres.2012.08.018.
↑  Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. . The Journal of Clinical Psychiatry. May 2008, 69 (5): 759–768. PMID 18452342. doi:10.4088/JCP.v69n0509.
↑  Every-Palmer S, Nowitz M, Stanley J, Grant E, Huthwaite M, Dunn H, Ellis, PM. . EBioMedicine. March 2016, 5: 125–134. PMC 4816835 . PMID 27077119. doi:10.1016/j.ebiom.2016.02.020.
↑  Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF. . The Journal of Clinical Psychiatry. 2012, 73 (10): 1307–1312. PMID 23140648. doi:10.4088/JCP.11r06977.
↑  Every-Palmer S, Newton-Howes G, Clarke MJ. . The Cochrane Database of Systematic Reviews. 24 January 2017, 1 (1): CD011128. PMID 28116777. doi:10.1002/14651858.CD011128.pub2.
↑  Every-Palmer S, Ellis PM, Nowitz M, Stanley J, Grant E, Huthwaite M, Dunn H. . CNS Drugs. January 2017, 31 (1): 75–85. PMID 27826741. doi:10.1007/s40263-016-0391-y.
↑  .   [2010-02-08]. （原始内容存档于2012-02-09）.
↑  rxlist.com / Clozapine side effects 的存檔，存档日期2007-11-04.
↑  Raja M. . Current Drug Safety. Jul 2011, 6 (3): 164–184. PMID 22122392. doi:10.2174/157488611797579230.
↑  Barnes TR, Drake MJ, Paton C. . The British Journal of Psychiatry. Jan 2012, 200 (1): 7–9. PMID 22215862. doi:10.1192/bjp.bp.111.095737.
↑  Ahmed S, Chengappa KN, Naidu VR, Baker RW, Parepally H, Schooler NR. . The Journal of Clinical Psychiatry. Sep 1998, 59 (9): 472–7. PMID 9771818. doi:10.4088/JCP.v59n0906.
↑  Szafrański T, Gmurkowski K. . Psychiatria Polska. 1999, 33 (1): 51–67. PMID 10786215.
↑  Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, Mintz J, Marder SR. . The Journal of Clinical Psychiatry. Jun 1999, 60 (6): 358–63. PMID 10401912. doi:10.4088/JCP.v60n0602.
↑  Nasrallah HA. . Molecular Psychiatry. Jan 2008, 13 (1): 27–35. PMID 17848919. doi:10.1038/sj.mp.4002066.
↑  Albaugh VL, Vary TC, Ilkayeva O, Wenner BR, Maresca KP, Joyal JL, Breazeale S, Elich TD, Lang CH, Lynch CJ. . Schizophrenia Bulletin. Jan 2012, 38 (1): 153–166. PMC 3245588 . PMID 20494946. doi:10.1093/schbul/sbq053.
↑  Sproule BA, Naranjo CA, Brenmer KE, Hassan PC. . Clinical Pharmacokinetics. Dec 1997, 33 (6): 454–71. PMID 9435993. doi:10.2165/00003088-199733060-00004.
↑  Tiihonen J, Vartiainen H, Hakola P. . Pharmacopsychiatry. Jan 1995, 28 (1): 26–28. PMID 7746842. doi:10.1055/s-2007-979584.
↑  Besag, FM; Berry, D. . Drug Saf. 2006, 29 (2): 95–118. PMID 16454538. doi:10.2165/00002018-200629020-00001.
↑  Jerling, M; Lindstrom, L; Bondesson, U;  et al. . Ther Drug Monit. 1994, 16 (4): 368–74. PMID 7974626. doi:10.1097/00007691-199408000-00006.
↑  Bitter R, Demler TL, Opler L. . Journal of Psychiatric Practice. Sep 2008, 14 (5): 265–70. PMID 18832957. doi:10.1097/01.pra.0000336753.11943.7c.
↑  Raaska K, Neuvonen PJ. . European Journal of Clinical Pharmacology. Nov 2000, 56 (8): 585–9. PMID 11151749. doi:10.1007/s002280000192.
↑  规定的信息。 Clozaril(氯氮平的)。 东Hanover,NJ：诺华医药公司、日2014年。
1 2  Roth, BL; Driscol, J. . Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health.   [14 August 2017]. （原始内容存档于2021-08-28）.
1 2  Roth, BL; Driscol, J. . Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health.   [14 August 2017]. （原始内容存档于2021-08-28）.
↑  Naheed M, Green B. . Current Medical Research and Opinion. 2001, 17 (3): 223–9. PMID 11900316. doi:10.1185/0300799039117069.
↑  Robinson DS. . Primary Psychiatry. 2007, 14 (8): 22–24. （原始内容存档于2012-01-18）.
↑  . pubchem.ncbi.nlm.nih.gov.   [16 July 2017]. （原始内容存档于24 December 2013） （英语）.
↑   Nair, P.C., McKinnon, R.A., Miners, J.O. et al. Binding of clozapine to the GABAB receptor: clinical and structural insights. Mol Psychiatry 25, 1910–1919 (2020). https://doi.org/10.1038/s41380-020-0709-5
↑  Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M. . British Journal of Pharmacology. Mar 2012, 165 (5): 1543–55. PMC 3372736 . PMID 21880034. doi:10.1111/j.1476-5381.2011.01638.x.
↑  Xi D, Li YC, Snyder MA, Gao RY, Adelman AE, Zhang W, Shumsky JS, Gao WJ. . Neuropsychopharmacology. May 2011, 36 (6): 1260–74. PMC 3079418 . PMID 21326193. doi:10.1038/npp.2011.12.
1 2  Rostami-Hodjegan A, Amin AM, Spencer EP, Lennard MS, Tucker GT, Flanagan RJ. . Journal of Clinical Psychopharmacology. Feb 2004, 24 (1): 70–8. PMID 14709950. doi:10.1097/01.jcp.0000106221.36344.4d.
↑  Lane HY, Chang YC, Chang WH, Lin SK, Tseng YT, Jann MW. . The Journal of Clinical Psychiatry. Jan 1999, 60 (1): 36–40. PMID 10074876. doi:10.4088/JCP.v60n0108.
↑  Novartis Pharmaceuticals.  (PDF). Novartis Pharmaceuticals: 36. April 2006  [2007-06-29]. （原始内容存档于2008-10-23）.
↑  Crilly J. . History of Psychiatry. Mar 2007, 18 (1): 39–60. PMID 17580753. doi:10.1177/0957154X07070335.
↑  Healy, David. . Cambridge: Harvard University Press. 2004: 238–42. ISBN 978-0-674-01599-9.
↑  Griffith, R.W.; Saameli, K. . The Lancet. 1975, 306 (7936): 657. doi:10.1016/s0140-6736(75)90135-x.
↑   (PDF). United States Food and Drug Administration. December 18, 2002  [November 23, 2012]. （原始内容存档 (PDF)于November 23, 1012）.
↑   (PDF).   [2009-09-20]. （原始内容存档 (PDF)于2011-05-11）.
Template:Tricyclics
N-desmethylclozapine （norclozapine）、氯氮平的主要活动的代谢物。